Community 365 Roundtable on New Treatment Paradigms

Since the launch of Europe’s Beating Cancer Plan in 2021, science and technology have not stood still. New and innovative approaches towards cancer detection, diagnosis and treatment are arriving at an ever rapid pace, and include, but are not limited to, for example, cell therapy, radioligand therapy and the use of liquid biopsy. ECO’s Community 365 Roundtable on New Treatment Paradigms will discuss the exciting potential of some of these approaches and the policy challenges of introducing them more widely in countries across Europe.

 

Experts from the clinician, patient, governmental and political environments will join us at the event to provide their experience and perspectives. Results of the discussions will be published in a detailed action report.

 

Please join us on Wednesday 12 June at 15:00-17:30 CEST for what promises to be a most illuminating conversation!

12 June 2024 15:00 - 17:30 CEST

Virtual

Apply for Registration

The roundtable will be co-chaired by Nikolina Dodlek, ECO Board Member and Young Cancer Nurse, European Oncology Nursing Society, and Erik Briers, PAC Advisory Committee Member and Vice Chairman, Europa Uomo.

 

Programme

15:00-15:10 - Welcome and introductions
15:110-15:55 - Cell therapy
15:55-16:40 - Radioligand therapy
16:40-17:25 - Liquid biopsy
17:25-17:30 - Event conclusions

 

More details on the full programme coming soon.

Speakers

  • Nikolina Dodlek Board Member, European Cancer Organisation; Young Cancer Nurse, European Oncology Nursing Society
  • Erik Briers Patient Advisory Committee Member, European Cancer Organisation; Vice Chairman, Europa Uomo
  • Ken Herrmann Chair - Oncology & Theranostics Committee, European Association of Nuclear Medicine (EANM)
  • Umberto Malapelle Researcher in Anatomic Pathology, Department of Public Health, University of Naples “Federico II”

Speakers

  • Nikolina Dodlek Board Member, European Cancer Organisation; Young Cancer Nurse, European Oncology Nursing Society
  • Erik Briers Patient Advisory Committee Member, European Cancer Organisation; Vice Chairman, Europa Uomo
  • Ken Herrmann Chair - Oncology & Theranostics Committee, European Association of Nuclear Medicine (EANM)
  • Umberto Malapelle Researcher in Anatomic Pathology, Department of Public Health, University of Naples “Federico II”
  • Nikolina Dodlek Board Member, European Cancer Organisation; Young Cancer Nurse, European Oncology Nursing Society Read Bio
  • Erik Briers Patient Advisory Committee Member, European Cancer Organisation; Vice Chairman, Europa Uomo Read Bio
  • Ken Herrmann Chair - Oncology & Theranostics Committee, European Association of Nuclear Medicine (EANM) Read Bio
  • Umberto Malapelle Researcher in Anatomic Pathology, Department of Public Health, University of Naples “Federico II” Read Bio
  • Leonhard Schaetz International Head of Health System Readiness and Partnership - Radioligand Therapies, Novartis Read Bio

Speakers

  • Nikolina Dodlek Board Member, European Cancer Organisation; Young Cancer Nurse, European Oncology Nursing Society
  • Erik Briers Patient Advisory Committee Member, European Cancer Organisation; Vice Chairman, Europa Uomo
  • Ken Herrmann Chair - Oncology & Theranostics Committee, European Association of Nuclear Medicine (EANM)
  • Umberto Malapelle Researcher in Anatomic Pathology, Department of Public Health, University of Naples “Federico II”

Speakers

  • Nikolina Dodlek Board Member, European Cancer Organisation; Young Cancer Nurse, European Oncology Nursing Society
  • Erik Briers Patient Advisory Committee Member, European Cancer Organisation; Vice Chairman, Europa Uomo
  • Ken Herrmann Chair - Oncology & Theranostics Committee, European Association of Nuclear Medicine (EANM)
  • Umberto Malapelle Researcher in Anatomic Pathology, Department of Public Health, University of Naples “Federico II”